Paula Doherty Johnson is a Senior Research Fellow with Harvard University’s Hauser Institute for Civil Society at the Center for Public Leadership, where she leads research on the growth, practices, and impact of global philanthropy. Ms. Johnson has twenty-five years of experience in global philanthropy and international development, with particular focus on the nexus of the two fields. She has conducted extensive research on and analysis of global philanthropic growth, institutions and practices....
Amy Boldosser-Boesch is senior director and head of the FCI Program of MSH within the Health Programs Group, based in MSH's New York office. Amy leads the FCI Program of MSH team's advocacy and accountability work for improved reproductive, maternal, newborn, and adolescent health and for access to universal health coverage.
Judith Seltzer is the Senior Director of the Performance, Learning and Impact unit at MSH. In this capacity, she leads a team of diverse specialists who provide knowledge management, research, and monitoring and evaluation support across the organization.
Helena Walkowiak is currently a Principal Technical Advisor with the Center for Pharmaceutical Management. She has seventeen years of experience in providing technical assistance in pharmaceutical management to health programs in Africa, Asia, Eastern Europe, and the Caribbean. Ms.
Jason Wright is a global health leader who brings to MSH more than 17 years of experience in family planning and reproductive health, HIV/AIDS, malaria, tuberculosis, and broader health systems with a focus on building the capacity of governments and nongovernmental organizations to bolster programmatic and financial sustainability through management and technical assistance.
Director Technical Strategy and Quality, Pharmaceuticals and Health Technologies Group
David Lee Chin, M.D., is Director Technical Strategy and Quality for the Pharmaceuticals and Health Technologies Group. He has over 30 years of experience in pharmaceutical management, including training, operations research and evaluation, and providing technical assistance to enhance access to and rational use of medicines in Africa, Asia, and the Americas. Dr. Lee is responsible for technical strategy oversight of PHT projects and designing and managing pharmaceutical sector studies. In addition to his medical degree and residency in pediatrics, he is also trained in Clinical Pharmacology.